MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-KL-02-0010061
Akesiss Pharma Private Limited - pharma in Kochi, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹72.51 Cr
▲ 22% YoY
Net profit · FY 2025
₹6.7 Cr
Net margin 9.2%
EBITDA · FY 2025
₹10.92 Cr
EBITDA margin 15.1%
Authorised capital
₹45 Lakh
Registered with MCA
Paid-up capital
₹45 Lakh
Issued & subscribed
Open charges
₹3.99 Cr
Satisfied ₹1.83 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
251
Provident fund records
About Akesiss Pharma Private Limited
Data last updated:
Akesiss Pharma Private Limited is a private limited company based in Kochi, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 November 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24232KL2008PTC023419. Its GSTIN is 32AAHCA4149C1Z6 (Kerala). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹45 Lakh and a paid-up capital of ₹45 Lakh. It is led by directors including Ashok Kumar Kannampalam (Managing Director) and Sharatkumar Kumarakurup (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rizwan Estate Pathadipalam Edappally, Kochi, Kerala, India – 682024.
As per the financials filed for FY 2025, the company reported a revenue of ₹72.51 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹6.7 Cr (net margin 9.2%) and EBITDA of ₹10.92 Cr (EBITDA margin 15.1%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 9% over five years.
The company has about 251 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Akesiss. As per MCA filings, the company has open charges of ₹3.99 Cr and satisfied charges of ₹1.83 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it. The company has 13 deals on record (12 secondary share transfers, 1 funding round), with disclosed funding of ₹34.5 Lakh; the latest was in March 2024.
Akesiss Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0010061). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website akesiss.com.
Company details
CIN U24232KL2008PTC023419
Registration Number 023419
Incorporation Date 18 November 2008
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KL-02-0010061
Key People
Ashok Kumar Kannampalam Managing Director Sharatkumar Kumarakurup Whole-Time Director Padmadas Panjajanyam Whole-Time Director Recognitions & Rankings of Akesiss Pharma
Contact details
Akesiss Pharma Private Limited's registered office is in Kochi, Kerala. Its website is akesiss.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressRizwan Estate Pathadipalam Edappally, Kochi, Kerala, India – 682024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Akesiss Pharma Private Limited, buy the company report.
Comprehensive company report
Akesiss Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Akesiss Pharma operates one associated brand: Akesiss. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and marketing of affordable medicines in the healthcare sector. | akesiss.com |
Business activity
The main business activity of Akesiss Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Akesiss Pharma Private Limited, buy the company report.
Financials of Akesiss Pharma Private Limited
FY 2025 filings availableAkesiss Pharma Private Limited reported revenue of ₹72.51 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹72.51 Cr ▲ 22%
Net profit · FY 2025
₹6.7 Cr margin 9.2%
EBITDA · FY 2025
₹10.92 Cr margin 15.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 11%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 20%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 22% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.92 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.7 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.1% | ||||
| Net Profit Margin | 9.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Akesiss Pharma Private Limited, buy the company report.
Board of directors of Akesiss Pharma Private Limited
Akesiss Pharma has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharatkumar Kumarakurup Also directs: Akesiss Healthcare LLP, Megasys Biotek Private Limited | Whole-Time Director | 18 Nov 2008 | 17 Years 11 Months | Current |
| Padmadas Panjajanyam Also directs: Akesiss Healthcare LLP, Megasys Biotek Private Limited | Whole-Time Director | 18 Nov 2008 | 17 Years 11 Months | Current |
| Ashok Kumar Kannampalam Also directs: Akesiss Healthcare LLP, Megasys Biotek Private Limited | Managing Director | 18 Nov 2008 | 17 Years 11 Months | Current |
| Thomsan George Also directs: Akesiss Healthcare LLP, Megasys Biotek Private Limited | Whole-Time Director | 18 Nov 2008 | 17 Years 11 Months | Current |
| Narayan Biji Also directs: Megasys Biotek Private Limited | Director | 01 Jan 2013 | 13 Years 9 Months | Current |
Auditor
Akesiss Pharma Private Limited is audited by BOBY FRANCIS & PRADEEP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BOBY FRANCIS & PRADEEP | FY 2023 | 202145 |
Shareholding
The shareholding of Akesiss Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Akesiss Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.99 Cr
Satisfied charges
₹1.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2023 | 100745046 | Hdfc Bank Limited | ₹72 Lakh | Open | |
| 04 Nov 2022 | 100644454 | Others | ₹1 Cr | Open | |
| 15 Jan 2022 | 100528831 | Hdfc Bank Limited | ₹7 Lakh | Open | |
| 15 Oct 2009 | 10182516 | State Bank of India | ₹2.2 Cr | Open | |
| 29 Mar 2017 | 100092747 | Others | ₹1 Cr | Satisfied |
To see the full charge records of Akesiss Pharma Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Akesiss Pharma Private Limited has 13 deals on record (12 secondary share transfers, 1 funding round), with disclosed funding of ₹34.5 Lakh; the latest was in March 2024.
Total deals
13
Secondary share transfers
12
Funding round
1
Disclosed funding
₹34.5 Lakh
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
To see the full deal history of Akesiss Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Akesiss Pharma Private Limited has 4 court cases on record: 3 filed by Akesiss Pharma, 1 filed against it. All cases are disposed.
Total cases
4
Filed by the company
3
Filed against the company
1
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
| High courts | 2 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ernakulam, Kerala | Civil suit | Filed by the company against Akumentis Healthcare Ltd and 3 others | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company | Disposed |
| High Court | Writ petition | Filed by the company against State Tax Officer and 4 others | Disposed |
| High Court | Writ petition | Filed by the company against individuals | Disposed |
To see the full case history of Akesiss Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Akesiss Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Akesiss Pharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Megasys Biotek Private Limited | U52311KL2005PTC017869 |
To see the full group structure of Akesiss Pharma Private Limited, buy the company report.
Employees & EPFO
Akesiss Pharma Private Limited has a workforce of 251 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
251
Active EPFO establishments
1
Employee growth
-2.33%
GST
Akesiss Pharma has 4 GST registrations: 4 active.
Total GSTINs
4
Active
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAHCA4149C1Z6 | Kerala | Active | 01 Jul 2017 |
| 27AAHCA4149C1ZX | Maharashtra | Active | 01 Jul 2017 |
| 29AAHCA4149C1ZT | Karnataka | Active | 01 Jul 2017 |
| 33AAHCA4149C1Z4 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Akesiss Pharma Private Limited, buy the company report.
Recent activity
Akesiss Pharma Private Limited has 9 board changes on record since 2008: 5 appointments and 4 cessations. The latest: Narayan Biji ceased to be Additional Director on 30 Sep 2013.
AGM
Akesiss Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Akesiss Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 72.00 Lakh with Charge ID 100745046 was registered on 27 Jun 2023.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100644454 was registered on 04 Nov 2022.
Charges
A charge registered on 29 Mar 2017 via Charge ID 100092747 with Others was fully satisfied on 17 Sep 2022.
Charges
A charge with State Bank Of India of Rs. 220.00 Lakh registered on 15 Oct 2009 with Charge ID 10182516 was modified on 08 Jul 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.00 Lakh with Charge ID 100528831 was registered on 15 Jan 2022.
Charges
A charge with Others of Rs. 100.00 Lakh registered on 29 Mar 2017 with Charge ID 100092747 was modified on 02 Jun 2017.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100092747 was registered on 29 Mar 2017.
Charges
A charge registered on 19 Dec 2013 via Charge ID 10472110 with Icici Bank Limited was fully satisfied on 26 Feb 2016.
Charges
A charge registered on 19 Dec 2013 via Charge ID 10472114 with Icici Bank Limited was fully satisfied on 26 Feb 2016.
Charges
A charge with Icici Bank Limited amounted to Rs. 33.00 Lakh with Charge ID 10472110 was registered on 19 Dec 2013.
12 earlier events are in the company report.
Frequently asked questions
Akesiss Pharma is an active private limited company based in Kochi, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 November 2008 (18+ years old) and is registered under CIN U24232KL2008PTC023419.
Akesiss Pharma has 5 current directors:
- Ashok Kumar Kannampalam - Managing Director
- Sharatkumar Kumarakurup - Whole-Time Director
- Padmadas Panjajanyam - Whole-Time Director
- Thomsan George - Whole-Time Director
- Narayan Biji - Director
The latest financial statements of Akesiss Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Akesiss Pharma is 32AAHCA4149C1Z6, registered in Kerala. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 27AAHCA4149C1ZX (Maharashtra), 29AAHCA4149C1ZT (Karnataka), 33AAHCA4149C1Z4 (Tamil Nadu).
The CIN (Corporate Identification Number) of Akesiss Pharma is U24232KL2008PTC023419. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akesiss Pharma has 4 court cases on record: 3 filed by the company and 1 filed against it. Most are in the district courts.
Akesiss Pharma was incorporated on 18 November 2008, making it 18+ years old. It is registered with the Registrar of Companies, Ernakulam.
Akesiss Pharma has 13 deals on record (12 secondary share transfers, 1 funding round), with disclosed funding of ₹34.5 Lakh; the latest was in March 2024.
Narayan Biji ceased to be Additional Director on 30 Sep 2013. Narayan Biji was appointed as Director on 01 Jan 2013. Ashok Kumar Kannampalam was appointed as Managing Director on 18 Nov 2008. Akesiss Pharma has 9 board changes on record in total.
Yes, Akesiss Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-KL-02-0010061).